Valion Bio, Inc. (VBIO) Revenue 2021–2024
Valion Bio, Inc. (VBIO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$780,000FY2024 · since FY2021: $1.3M → $780,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $780,000 | -33.7% |
| FY2023 | $1.2M | -36.1% |
| FY2022 | $1.8M | +46.4% |
| FY2021 | $1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VBIO financial trends
VBIO Net incomeVBIO Net marginVBIO Gross profitVBIO Gross marginVBIO Operating incomeVBIO Operating marginVBIO Operating cash flowVBIO Free cash flowVBIO Capital expendituresVBIO Return on equityVBIO Stock buybacksVBIO Dividends paidVBIO Total assetsVBIO Total liabilitiesVBIO Shareholders’ equityVBIO overview →